IAP Regulation of Metastasis

Cancer Cell

Volumn 17, Issue 1, 2010, Pages 53-64

  Mehrotra, Swarna ^a   Languino, Lucia R ^a   Raskett, Christopher M ^a   Mercurio, Arthur M ^a   Dohi, Takehiko ^a   Altieri, Dario C ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

CELLCYCLE

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN; FOCAL ADHESION KINASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; STEROID RECEPTOR COACTIVATOR 1; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CELL DEATH; CELL MOTILITY; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH;

INTRACISTERNAL A-PARTICLES;

EID: 73649095563     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2009.11.021     Document Type: Article

References (55)

1. Altieri D.C. Survivin, cancer networks and pathway-directed drug discovery. Nat. Rev. Cancer 8 (2008) 61-70
2. Birkey Reffey S., Wurthner J.U., Parks W.T., Roberts A.B., and Duckett C.S. X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signaling. J. Biol. Chem. 276 (2001) 26542-26549
3. Bittner M., Meltzer P., Chen Y., Jiang Y., Seftor E., Hendrix M., Radmacher M., Simon R., Yakhini Z., Ben-Dor A., et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406 (2000) 536-540
4. Bouchard V., Harnois C., Demers M.J., Thibodeau S., Laquerre V., Gauthier R., Vezina A., Noel D., Fujita N., Tsuruo T., et al. B1 integrin/Fak/Src signaling in intestinal epithelial crypt cell survival: integration of complex regulatory mechanisms. Apoptosis 13 (2008) 531-542
5. Bredesen D.E., Mehlen P., and Rabizadeh S. Receptors that mediate cellular dependence. Cell Death Differ. 12 (2005) 1031-1043
6. Clark E.A., Golub T.R., Lander E.S., and Hynes R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406 (2000) 532-535
7. Cory S., and Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2 (2002) 647-656
8. Cukierman E., Pankov R., and Yamada K.M. Cell interactions with three-dimensional matrices. Curr. Opin. Cell Biol. 14 (2002) 633-639
9. Dogan T., Harms G.S., Hekman M., Karreman C., Oberoi T.K., Alnemri E.S., Rapp U.R., and Rajalingam K. X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility. Nat. Cell Biol. 10 (2008) 1447-1455
10. Dohi T., Okada K., Xia F., Wilford C.E., Samuel T., Welsh K., Marusawa H., Zou H., Armstrong R., Matsuzawa S., et al. An IAP-IAP complex inhibits apoptosis. J. Biol. Chem. 279 (2004) 34087-34090
11. Dohi T., Xia F., and Altieri D.C. Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol. Cell 27 (2007) 17-28
12. Fornaro M., Plescia J., Chheang S., Tallini G., Zhu Y.M., King M., Altieri D.C., and Languino L.R. Fibronectin protects prostate cancer cells from tumor necrosis factor-{alpha}-induced apoptosis via the AKT/survivin pathway. J. Biol. Chem. 278 (2003) 50402-50411
13. Frisch S.M., and Screaton R.A. Anoikis mechanisms. Curr. Opin. Cell Biol. 13 (2001) 555-562
14. Gaggioli C., Robert G., Bertolotto C., Bailet O., Abbe P., Spadafora A., Bahadoran P., Ortonne J.P., Baron V., Ballotti R., and Tartare-Deckert S. Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway. J. Invest. Dermatol. 127 (2007) 400-410
15. Geisbrecht E.R., and Montell D.J. A role for Drosophila IAP1-mediated caspase inhibition in Rac-dependent cell migration. Cell 118 (2004) 111-125
16. Ginsberg M.H., Partridge A., and Shattil S.J. Integrin regulation. Curr. Opin. Cell Biol. 17 (2005) 509-516
17. Han S., Ritzenthaler J.D., Sitaraman S.V., and Roman J. Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J. Biol. Chem. 281 (2006) 29614-29624
18. Helleman J., Jansen M.P., Ruigrok-Ritstier K., van Staveren I.L., Look M.P., Meijer-van Gelder M.E., Sieuwerts A.M., Klijn J.G., Sleijfer S., Foekens J.A., and Berns E.M. Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response. Clin. Cancer Res. 14 (2008) 5555-5564
19. Hinnis A.R., Luckett J.C., and Walker R.A. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients. Br. J. Cancer 96 (2007) 639-645
20. Hofer-Warbinek R., Schmid J.A., Stehlik C., Binder B.R., Lipp J., and de Martin R. Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J. Biol. Chem. 275 (2000) 22064-22068
21. Hughes P.E., Renshaw M.W., Pfaff M., Forsyth J., Keivens V.M., Schwartz M.A., and Ginsberg M.H. Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 88 (1997) 521-530
22. Irie H.Y., Pearline R.V., Grueneberg D., Hsia M., Ravichandran P., Kothari N., Natesan S., and Brugge J.S. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell Biol. 171 (2005) 1023-1034
23. Juliano R.L., Reddig P., Alahari S., Edin M., Howe A., and Aplin A. Integrin regulation of cell signalling and motility. Biochem. Soc. Trans. 32 (2004) 443-446
24. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., MacDonald D.D., Jin D.K., Shido K., Kerns S.A., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
25. Lewis J., Burstein E., Reffey S.B., Bratton S.B., Roberts A.B., and Duckett C.S. Uncoupling of the signaling and caspase-inhibitory properties of X-linked inhibitor of apoptosis. J. Biol. Chem. 279 (2004) 9023-9029
26. Liu Z., Li H., Wu X., Yoo B.H., Yan S.R., Stadnyk A.W., Sasazuki T., Shirasawa S., LaCasse E.C., Korneluk R.G., and Rosen K.V. Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cells. Oncogene 25 (2006) 7680-7690
27. Livant D.L., Brabec R.K., Kurachi K., Allen D.L., Wu Y., Haaseth R., Andrews P., Ethier S.P., and Markwart S. The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice. J. Clin. Invest. 105 (2000) 1537-1545
28. Lu M., Lin S.C., Huang Y., Kang Y.J., Rich R., Lo Y.C., Myszka D., Han J., and Wu H. XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol. Cell 26 (2007) 689-702
29. Mehlen P., and Puisieux A. Metastasis: a question of life or death. Nat. Rev. Cancer 6 (2006) 449-458
30. Mitra S.K., and Schlaepfer D.D. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 18 (2006) 516-523
31. Moissoglu K., and Gelman I.H. v-Src rescues actin-based cytoskeletal architecture and cell motility and induces enhanced anchorage independence during oncogenic transformation of focal adhesion kinase-null fibroblasts. J. Biol. Chem. 278 (2003) 47946-47959
32. Naugler W.E., and Karin M. NF-[kappa]B and cancer-identifying targets and mechanisms. Curr. Opin. Genet. Dev. 18 (2008) 19-26
33. Nelson C.M., and Bissell M.J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 22 (2006) 287-309
34. Nguyen D.X., and Massague J. Genetic determinants of cancer metastasis. Nat. Rev. Genet. 8 (2007) 341-352
35. Nobes C.D., and Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81 (1995) 53-62
36. Oshima K., Takeda M., Kuranaga E., Ueda R., Aigaki T., Miura M., and Hayashi S. IKK epsilon regulates F actin assembly and interacts with Drosophila IAP1 in cellular morphogenesis. Curr. Biol. 16 (2006) 1531-1537
37. Parsons J.T., Slack-Davis J., Tilghman R., and Roberts W.G. Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention. Clin. Cancer Res. 14 (2008) 627-632
38. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., Reinhart-King C.A., Margulies S.S., Dembo M., Boettiger D., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8 (2005) 241-254
39. Pohl C., and Jentsch S. Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. Cell 132 (2008) 832-845
40. Resch U., Schichl Y.M., Winsauer G., Gudi R., Prasad K., and de Martin R. Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis. J. Cell Sci. 122 (2009) 2651-2661
41. Salz W., Eisenberg D., Plescia J., Garlick D.S., Weiss R.M., Wu X.R., Sun T.T., and Altieri D.C. A survivin gene signature predicts aggressive tumor behavior. Cancer Res. 65 (2005) 3531-3534
42. Sanna M.G., Duckett C.S., Richter B.W., Thompson C.B., and Ulevitch R.J. Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc. Natl. Acad. Sci. USA 95 (1998) 6015-6020
43. Scheel C., Onder T., Karnoub A., and Weinberg R.A. Adaptation versus selection: the origins of metastatic behavior. Cancer Res. 67 (2007) 11476-11479 discussion 11479-11480
44. Sieg D.J., Hauck C.R., Ilic D., Klingbeil C.K., Schaefer E., Damsky C.H., and Schlaepfer D.D. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2 (2000) 249-256
45. Slack J.K., Catling A.D., Eblen S.T., Weber M.J., and Parsons J.T. c-Raf-mediated inhibition of epidermal growth factor-stimulated cell migration. J. Biol. Chem. 274 (1999) 27177-27184
46. Srinivasula S.M., and Ashwell J.D. IAPs: what's in a name?. Mol. Cell 30 (2008) 123-135
47. Stupack D.G., Teitz T., Potter M.D., Mikolon D., Houghton P.J., Kidd V.J., Lahti J.M., and Cheresh D.A. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 439 (2006) 95-99
48. Talmadge J.E. Clonal selection of metastasis within the life history of a tumor. Cancer Res. 67 (2007) 11471-11475
49. Thomas J., Liu T., Cotter M.A., Florell S.R., Robinette K., Hanks A.N., and Grossman D. Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice. Cancer Res. 67 (2007) 5172-5178
50. Varfolomeev E., Blankenship J.W., Wayson S.M., Fedorova A.V., Kayagaki N., Garg P., Zobel K., Dynek J.N., Elliott L.O., Wallweber H.J., et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131 (2007) 669-681
51. Weigelt B., Peterse J.L., and van 't Veer L.J. Breast cancer metastasis: markers and models. Nat. Rev. Cancer 5 (2005) 591-602
52. Williams C.M., Engler A.J., Slone R.D., Galante L.L., and Schwarzbauer J.E. Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res. 68 (2008) 3185-3192
53. Yao E.S., Zhang H., Chen Y.-Y., Lee B., Chew K., Moore D., and Park C. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res. 67 (2007) 659-664
54. Yeatman T.J. A renaissance for SRC. Nat. Rev. Cancer 4 (2004) 470-480
55. Zheng Y., Xia Y., Hawke D., Halle M., Tremblay M.L., Gao X., Zhou X.Z., Aldape K., Cobb M.H., Xie K., et al. FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. Mol. Cell 35 (2009) 11-25